Isoptin

Verapamil Hydrochloride, the active ingredient in Isoptin, is a calcium channel blocker presented as a sterile injectable solution for intravenous use. It is employed to manage hypertension, angina pectoris and supraventricular arrhythmias in adult patients. GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoptin, a calcium channel blocker, is used to treat cardiovascular conditions by modulating calcium influx. - Hypertension: lowers elevated blood pressure by relaxing vascular smooth muscle. - Angina pectoris: reduces frequency and severity of chest pain through coronary vasodilation. - Supraventricular arrhythmias: controls abnormal heart rhythms such as atrial fibrillation by slowing atrioventricular nodal conduction.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after infusion. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the lower extremities. - Constipation: reduced bowel motility. - Dizziness: sensation of light‑headedness. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Bradycardia: abnormally slow heart rate. - AV block: impaired atrioventricular conduction. - Exacerbation of heart failure: worsening symptoms of cardiac insufficiency. - Allergic reactions: rash, itching, or anaphylaxis. - Elevated liver enzymes: signs of hepatic injury.

Before initiating therapy, clinicians should assess cardiovascular status and monitor for adverse reactions. - Monitor blood pressure: ensure values remain within target range. - Monitor heart rate: watch for bradycardia or arrhythmias. - Use cautiously in heart failure: risk of negative inotropic effect. - Avoid in severe hepatic impairment: altered drug metabolism. - Adjust in renal impairment: consider accumulation risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Verapamil may interact with several medicines, requiring careful management. Major Interactions (Avoid): - Beta‑blockers: additive bradycardia and hypotension. - Digoxin: increased serum digoxin levels, risk of toxicity. - Diltiazem: combined AV nodal suppression leading to heart block. Moderate Interactions (Monitor Closely): - Strong CYP3A4 inhibitors (e.g., ketoconazole): elevate verapamil concentrations. - Strong CYP3A4 inducers (e.g., rifampin): reduce verapamil effectiveness.